Microfluidic Bacterial Classification via Optical Scattering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for bacterial classification and antimicrobial susceptibility testing are either time-consuming due to culturing requirements or require specialized knowledge and equipment, and often provide incomplete or mismatched resistance profiles.
Innovation Solution
A microfluidic device-based method that exposes bacterial cells to multiple antimicrobial agents and salt mixtures to classify them based on phenotype responses, enabling simultaneous determination of minimum inhibitory concentration (MIC) and clinical breakpoint (CBP) values, thereby determining antimicrobial effectiveness.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If phenotypic methods (agar plates, disc diffusion) are used for AST, then bacteria classification accuracy is improved, but testing time increases significantly due to overnight culturing requirements
Solution Approach 1:
The patent replaces traditional mechanical/cultural phenotypic methods with optical detection. The system uses a microfluidic device combined with optical scattering detection to measure bacterial susceptibility to antibiotics in real-time, eliminating the need for overnight culturing while maintaining classification accuracy. The optical system detects changes in light scattering properties as bacteria respond to antibiotic treatment, providing rapid results within hours.
Solution Approach 2:
The patent changes the detection parameter from visual observation of bacterial growth zones to optical scattering measurements. By monitoring the scattering properties of light as it passes through the microfluidic device containing bacteria and antibiotics, the system can detect susceptibility responses dynamically without requiring extended incubation periods for visible colony formation.
2Loss of time
If genetic methods (PCR, DNA microarrays) are used for AST, then testing time is reduced compared to phenotypic methods, but device complexity and expertise requirements increase
Solution Approach 1:
The patent employs a disposable microfluidic device that integrates sample preparation, antibiotic exposure, and optical detection in a single-use format. This eliminates the need for complex, expensive, and reusable equipment like PCR machines or DNA sequencers, while maintaining rapid testing capabilities. The disposable nature reduces contamination risks and eliminates the need for specialized maintenance and operation expertise.
Solution Approach 2:
The microfluidic device is designed to perform multiple functions automatically without requiring specialized operational expertise. The system self-regulates fluid flow, mixing, and exposure conditions, while the optical detection system automatically analyzes scattering patterns and provides susceptibility results, reducing dependence on highly trained personnel.
3Loss of time
If genetic methods are used for AST, then rapid results are obtained, but resistance profile accuracy decreases due to mismatches between genotypic and phenotypic profiles
Solution Approach 1:
The patent replaces genetic analysis with direct optical observation of bacterial phenotypic response to antibiotics. By measuring light scattering changes that occur when bacteria are exposed to antibiotic treatments in the microfluidic device, the system directly assesses functional susceptibility rather than inferring it from genetic markers, ensuring accuracy matches traditional phenotypic methods while maintaining speed.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for rapid, efficient classification and analysis of bacterial cells, providing accurate antimicrobial susceptibility information in a single analysis, reducing time and expertise requirements while ensuring clinical relevance.
Implementation Method 1
classifying the bacterial cells from the biological sample at least based on (i) a phenotype characteristic response of the bacterial cells to the first antimicrobial agent or mixture
Data Source
AI summary
Bacterial cells from a biological sample are exposed to a test antimicrobial agent in addition to multiple other antimicrobial agents or mixtures. A MIC value of the test antimicrobial agent is determined based on a phenotypic characteristic response of the bacterial cells to the test antimicrobial agent. The bacterial cells are classified based on respective phenotype characteristic responses of the bacterial cells to the other antimicrobial agent or mixtures and the classification is used to determine a CBP value for the test antimicrobial agent. The MIC and CBP values are then determined and can be used to determine whether the bacterial cells from the biological sample are susceptible or not to the test antimicrobial agent.